Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
09/2002
09/12/2002WO2002069948A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
09/12/2002US20020128301 Non-nucleoside reverse transcriptase inhibitors
09/12/2002US20020128263 Treatment or prevention of mGluR5 receptor mediated disorders.
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020127502 Cyanine dye
09/12/2002CA2439666A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity
09/12/2002CA2439581A1 Use of gabaa inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin e for the treatment of cognitive disorders
09/11/2002EP1237869A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
09/11/2002EP0934309B1 New pyridyl alkane acid amides as cytostatics and immunosuppressives
09/11/2002EP0763036B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
09/11/2002CN1368961A Compounds for modulation of PPAP gamma activity
09/10/2002US6448286 Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors
09/10/2002US6448262 Pesticidal and parasiticidal use of 2-(substituted thio) thiazolo-[4,5-b]pyridine compounds
09/10/2002US6448261 Arylamino fused pyridines
09/10/2002US6448243 Serotonin antagonist for treating, ameliorating and preventing spastic paralysis or central muscle relaxants for ameliorating myotonia
09/10/2002US6448241 Thiazolobenzoheterocycles, their preparation and medicaments containing them
09/10/2002CA2195129C Substituted piperidine intermediates for producing heterocyclic-cyclic amine derivatives capable of inhibiting cholinesterase
09/10/2002CA2119853C Pyridothiadiazines; process for preparing the same and pharmaceutical compositions containing them
09/06/2002WO2002068421A2 Tricyclic compounds and their analogs as inhibitors of cytokine signaling
09/06/2002WO2002068415A1 Pyrazole compounds useful as protein kinase inhibitors
09/06/2002WO2002038563A3 Condensed pyrazindione derivatives as pde inhibitors
09/06/2002WO2002028860A3 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
09/06/2002WO2002012250A3 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
09/06/2002CA2426538A1 Tricyclic compounds and their uses
09/05/2002US20020123497 For therapy of cancer, neurofibromin benign proliferative disorder; blindness related to retinal vascularization; infections from hepatitis delta and related viruses; prophylaxis of restenosis; polycystic kidney disease
09/04/2002EP1235831A2 New oxabispidine compounds useful in the treatment of cardiac arrhythmias
09/04/2002EP1235792A1 Preparation of [4s-(4alpha,7alpha,10abeta)]-4-amino-octahydro-5-oxo-7h-pyrido 2,1-b] 1,3]thiazepine-7-carboxylic acid, methyl ester and salts thereof via novel disulfides
09/04/2002EP0724587B1 Ring-expanded nucleosides and nucleotides
09/03/2002US6444823 Pyridyl alkane acid amides as cytostatics and immunosuppressives
09/03/2002US6444810 Acylmercaptoalkanoylamino lactam esters or acids are converted to the corresponding mercaptoalkanoylamino lactam ester or acid under basic conditions using an agent that minimizes amount of disulfides
08/2002
08/29/2002WO2002066479A1 Novel isoindole derivatives
08/29/2002WO2002066461A1 Pyrazole compounds useful as protein kinase inhibitors
08/29/2002WO2002066035A2 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators
08/29/2002WO2002066034A1 Methods for treating metabolic diseases using malonyl-coa decarboxylase inhibitors
08/29/2002US20020119969 Potassium channel modulator; antidiabetic agents
08/28/2002EP1233967A1 Pyridinones to treat and prevent bacterial infections
08/27/2002US6441172 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
08/27/2002US6441019 Cyclocarbamate and cyclic amide derivatives
08/27/2002US6440993 IL-8 receptor antagonists
08/27/2002US6440992 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
08/27/2002US6440960 An oxygen or sulfure or sulfure oxide or dioxide containing tricyclic compouund useful for treating the disorder manifesting hypersecretion of corticotropin releasing factor
08/22/2002WO2002064599A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/22/2002WO2002064080A2 Matrix metalloproteinase inhibitors
08/22/2002US20020115854 Thrombin or factor Xa inhibitors
08/22/2002US20020115700 Inhibiting telomerase activity with 5-(3-Isatinylidinyl)thiazolidineones and 3-(thiazolidinon-5-yl) indoles
08/22/2002US20020115670 1-Aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
08/22/2002CA2437643A1 Matrix metalloproteinase inhibitors
08/22/2002CA2436371A1 Bicyclic pyrimidine matrix metalloproteinase inhibitors
08/15/2002WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors
08/15/2002WO2002062301A2 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/15/2002US20020111350 Aryl fused azapolycyclic compounds
08/15/2002CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails
08/14/2002EP1231210A2 Azole antifungal agents, processes for the preparation thereof, and intermediates
08/14/2002EP1230246A2 Novel thiophenes and method for polymerization of said thiophenes
08/14/2002EP1230235A1 Compounds with antibacterial and antiparasitic properties
08/14/2002EP0937076B1 Substituted oximes, hydrazones and olefins as neurokinin antagonists
08/14/2002CN1364167A Endogenous constitutively activated G protein-coupled orphan receptors
08/13/2002US6433171 Dipeptide derivatives
08/13/2002US6432945 Dipeptide derivatives
08/08/2002WO2002060907A1 Heterocyclic compounds and cerebral function improvers containing the same as the active ingredient
08/08/2002WO2002060894A2 Sulfonamide lactam inhibitors of factor xa
08/08/2002CA2436774A1 Sulfonamide lactam inhibitors of factor xa
08/07/2002EP1228073A2 Imidazole compounds used as phosphodiesterase vii inhibitors
08/07/2002EP1228063A2 Substituted pyridines and pyridazines with angiogenesis inhibiting activity
08/07/2002CN1362397A Dialkoyl-halogen phenyl substituted keto-enol
08/07/2002CN1088702C Disubstituted bicyclic heterocycles, their production and use as medicaments
08/06/2002US6429313 Growth hormone secretagogues useful for treatment/prevention of osteoporosis
08/01/2002WO2002059129A2 Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists
08/01/2002WO2002059124A2 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
08/01/2002WO2002059112A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002WO2002059111A2 Pyrazole compounds useful as protein kinase inhibitors
08/01/2002US20020103373 Tricyclic benzodiazepines as vasopressin receptor antagonists
08/01/2002US20020103211 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders
08/01/2002US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine
08/01/2002US20020103201 Selective NPY (Y5) antagonists (triazines)
08/01/2002US20020102435 Electroluminescence device, cyclic azine compound and production process of cyclic azine dye
07/2002
07/31/2002EP1227103A2 Ring-expanded nucleosides and nucleotides
07/31/2002EP1226146A2 Quinoline and naphthyridine carboxylic acid antibacterials
07/31/2002EP0880500B1 Esters of 3-hydroxy-piperidinemethanol derivatives
07/31/2002EP0527801B1 Thiophene sulfonamides useful as carbonic anhydrase inhibitors
07/31/2002CN1361783A Thiazoloderivatives and pharmaceutical compositions containing them
07/31/2002CN1361782A Substituted imidazothiazoles as antidepressant agents
07/25/2002WO2002057259A2 Pyrazole compounds useful as protein kinase inhibitors
07/25/2002WO2002056882A1 Quinolines and nitrogenated derivaive thereof substituted in 4-position by a piperidine-containing moiety and their use as antibacterial agents
07/25/2002WO2001090091A8 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
07/25/2002US20020099205 Cyclization of (2-Oxo-4-(2-oxo-2-(tetrahydrofuran-2-yl)-ethylsulfanyl)-3-phenylacetylamino -azetidin-1-yl)-(trimethyl- alpha -phosphanylidene)-acetic acid 4-nitro-benzyl ester; reacting with acid
07/25/2002US20020099071 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
07/25/2002US20020099065 Novel 3, 5, and/or 6 substituted analogues of swainsonine, processes for their preparation and their use as therapeutic agents
07/24/2002EP1224183A2 Heterocyclic sodium/proton exchange inhibitors and method
07/24/2002EP1224171A1 Beta disubstituted metalloprotease inhibitors
07/24/2002EP0988045A4 Peptide nucleic acid monomers and oligomers
07/24/2002EP0966473B1 Thiazolobenzoheterocycles, preparation and medicines containing same
07/24/2002EP0820454B1 Anellated beta-carbolines
07/23/2002US6423840 Forming n-acylamino compound
07/23/2002US6423715 Thiazolobenzoheterocycles, their preparation and medicaments containing them
07/23/2002CA2041594C Pyrido[2,3-f][1,4]thiazepines and pyrido[3,2-b][1,5]benzothiazepines
07/18/2002WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists
07/18/2002WO2002055507A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
07/18/2002WO2002004409A3 Tetrahydrobenzothiazole analogues as neuroprotective agents
07/18/2002CA2433960A1 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors